Empagliflozin lowers myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized 13C magnetic resonance spectroscopy study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Desiree
Abdurrachim
,
Xing Qi
Teo
,
Chern Chiuh
Woo
,
Wei Xin
Chan
,
Janise
Lalic
,
Carolyn S.P.
Lam
,
Philip Teck Hock
Lee Source Type: research
More News: Cardiology | Diabetes | Eating Disorders & Weight Management | Empagliflozin | Endocrinology | Heart | Heart Disease | Jardiance | Obesity | Study